MoonLake Immunotherapeutics (MLTX) stock

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30

$12.50−0.37 (-2.87%)

Close on Nov 13, 2026Market cap $1.06BP/E –Yield –

MoonLake Immunotherapeutics statistics

65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 22, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.06B; $272.32M
Enterprise Value: $565.33M; $146.23M
PB Ratio: 2.79; 2.00
P/TBV Ratio: 2.79; 2.22

Share statisticsIndustry

Shares Outstanding: 85M; 58M
Shares Change (YoY): 18.0%; 10.8%
Float: 34M; 49M
Shares Held by Insiders: 59.9%; 11.7%
Shares Held by Institutions: 86.3%; 56.4%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: -30.1%; -0.80%
Short % of Float: 16.0%; 9.01%
Short % of Shares Outstanding: 6.43%; 6.30%
Days to Cover: 2.85; 5.15

Stock price statisticsIndustry

52-Week High: $23.29; –
52-Week Low: $9.46; –
20-Day Moving Average: $11.82; –
50-Day Moving Average: $11.88; –
200-Day Moving Average: $16.26; –
Average True Range (14): $0.82; –
Price Change (1 Week): 8.41%; -1.15%
Price Change (1 Month): 21.8%; -4.87%
Price Change (3 Months): -23.5%; -21.0%
Price Change (6 Months): -28.8%; -20.6%
Price Change (YTD): -5.16%; -23.6%
Price Change (1 Year): -2.11%; -22.4%
Price Change (3 Years): -66.6%; -29.5%
Price Change (5 Years): 26.4%; -77.9%
Average Volume (10 Days): 1M; –
Average Volume (20 Days): 2M; –
Average Volume (90 Days): 2M; –
Relative Volume: 0.78; 0.70
Relative Strength Index (14): 54.1; 43.4
Volatility (1 Year): 74.0%; 80.1%
Beta (5 Years): 0.78; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -81.6%; -49.9%
Return on Assets (ROA): -57.3%; -40.6%
Return on Capital Employed (ROCE): -57.4%; -37.9%

Financial positionIndustry

Current Ratio: 9.13; 3.30
Quick Ratio: 8.53; 2.39
Interest Coverage: -28.98; -6.35

EfficiencyIndustry

Profits Per Employee: -$2.10M; -$689.41K
Employee Count: 130; 74
WACC: 8.99%; 10.2%

Income statement (TTM)Industry

Operating Income: -$276.75M; -$21.37M
Net Income: -$273.48M; -$22.35M
EBITDA: -$273.36M; -$17.21M
EPS (Diluted): -$3.67; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $498.50M; $68.68M
Net Cash (Debt): $498.50M; $17.76M
Net Cash Per Share: $5.86; $0.80
Equity (Book Value): $381.63M; $53.89M
Book Value Per Share: $4.48; $1.50
Tangible Book Value: $381.63M; $27.13M
Working Capital: $474.91M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$244.04M; -$12.38M
Capital Expenditures: $0; -$1.00M
Free Cash Flow: -$244.04M; -$18.21M
FCF Per Share: -$2.87; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -25.7%; -21.8%
FCF Yield: -22.9%; -9.44%

Taxes and interestIndustry

Interest Expense: $9.55M; $2.90M
Income Tax: $1.59M; $73.00K

Scores and fair valueIndustry

Altman Z-Score: 1.63; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MLTX	S&P 500	Difference	MLTX per year	S&P 500 per year
1 month	+20.1%	-3.0%	+23.1 pts
3 months	-24.2%	-2.8%	−21.5 pts
Year to date	-5.2%	+11.5%	−16.6 pts
1 year	-0.5%	+13.5%	−13.9 pts
3 years	-65.9%	+77.7%	−143.6 pts	-30.1%	+21.1%
5 years	+26.4%	+72.6%	−46.2 pts	+4.8%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M MLTX shares were sold short on Oct 30, 2026, down 30.1% from the previous report, or 16.05% of the shares available to trade. At recent volumes it would take 2.9 days to buy them back. Over the last 20 sessions, 46.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,473,842	-30.1%	1,918,072	2.9
Oct 15, 2026	7,833,997	-2.7%	1,920,537	4.1
Sep 30, 2026	8,048,665	-10.0%	1,901,006	4.2
Sep 15, 2026	8,947,906	+25.2%	1,473,823	6.1
Aug 31, 2026	7,144,513	+4.8%	1,070,171	6.7
Aug 14, 2026	6,819,147	+19.2%	1,615,874	4.2
Jul 31, 2026	5,721,976	-9.7%	864,693	6.6
Jul 15, 2026	6,334,566	-3.4%	1,268,600	5.0
Jun 30, 2026	6,557,634	+23.3%	1,856,799	3.5
Jun 15, 2026	5,319,238	-4.5%	736,814	7.2
May 29, 2026	5,568,411	+1.8%	803,977	6.9
May 15, 2026	5,467,746	-13.5%	1,095,540	5.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?